Genome-wide association study of medication-use and associated disease in the UK Biobank
An understanding of the genetic variants associated with medication use may shed light on the underlying biological pathways of disease, and aid in drug development. Here, Wu and colleagues conduct a GWAS for self-reported medication-use in the UK Biobank, finding more than 500 independent variants...
Enregistré dans:
Auteurs principaux: | Yeda Wu, Enda M. Byrne, Zhili Zheng, Kathryn E. Kemper, Loic Yengo, Andrew J. Mallett, Jian Yang, Peter M. Visscher, Naomi R. Wray |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7a2b184ba1cd45c1aa138f729b16fae8 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Extreme inbreeding in a European ancestry sample from the contemporary UK population
par: Loic Yengo, et autres
Publié: (2019) -
Reproducibility in the UK biobank of genome-wide significant signals discovered in earlier genome-wide association studies
par: Jack W. O’Sullivan, et autres
Publié: (2021) -
Genome-wide association study suggests that variation at the RCOR1 locus is associated with tinnitus in UK Biobank
par: Helena R. R. Wells, et autres
Publié: (2021) -
Genome-wide association study of depression phenotypes in UK Biobank identifies variants in excitatory synaptic pathways
par: David M. Howard, et autres
Publié: (2018) -
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
par: Angli Xue, et autres
Publié: (2018)